Team
IGES Pharma provides solutions for your market access challenges. We consider our broad experience as a toolbox at your service. Depending on your needs and specifications, tailored solutions are put together from one source, integrating expertise and experts from our subsidiaries in Europe as needed.

Dr. Amir Ansaripour
Health Economics & Outcomes Research

Katharina Barton
Value & Access Strategy

Eika Louisa Bergemann
HTA & Value Demonstration

Fabian Berkemeier
Managing Director Pharma & Biotech

Dr. Jolantha Beyerle
HTA & Value Demonstration

Dr. Barbara Bosch
HTA & Value Demonstration

Wiebke Braunschweig
Statistics & Biometrics

Susanne Brückel
HTA & Value Demonstration

Agata Daroszewska
Public Affairs

Dr. Veronika Deák
Value & Access Strategy

Marie Derstroff
Value & Access Strategy

Dr. Katrin Domes-Martin
HTA & Value Demonstration

Alice Elisabeth dos Reis Dias Heller
HTA & Value Demonstration

Saskia Ehrenfried
HTA & Value Demonstration

Undine Euker
HTA & Value Demonstration

Gamze Fackelmann
Health Economics & Outcomes Research

Dr. Norbert Gerbsch
Public Affairs

Melissa Gomez Montero
Health Economics & Outcomes Research

Peter Gray
Statistics & Biometrics

Donald Lorenz Gujer
HTA & Value Demonstration

Prof. Dr. Bertram Häussler
Chairman of the Board of Management Health Services Research

Stefan Hargesheimer
Value & Access Strategy

Carl-Christoph Henkel
Clinical Research

Dr. Jana Heppt
HTA & Value Demonstration

Juna Hertlein
Value & Access Strategy

Dr. Ariane Höer
Pharmaceutical Market Research

Dr. Pascale Holzerny
HTA & Value Demonstration

Bennet Huebbe
Value & Access Strategy

Dr. Mehdi Javanbakht
Director Health Economics & Outcomes Research

Sandra Jessel
Public Affairs

Vasileios Kontogiannis
Health Economics & Outcomes Research

Wioletta Kotowa
Authorized Signatory Pharma & Biotech

Heidi Kulas
Statistics & Biometrics

Dr. Marc Kurepkat
CEO Clinical Research

Julia Isabella Krieger
Value & Access Strategy

Florentine Lang
HTA & Value Demonstration

Hong Anh Le
Value & Access Strategy

Lukas Maag
Pharmaceutical Market Research

Dr. Tilo Mandry
Lead International Liaison Manager

Karina Manz
Value & Access Strategy

Tamsin Markanday
Market Access UK

Atefeh Mashayekhi
Health Economics & Outcomes Research

Jörg Mathes
HTA & Value Demonstration

Dr. Ann-Katrin Menzner
HTA & Value Demonstration

Tatjana Meyer
HTA & Value Demonstration

Pierre Moïse
General Manager IGES France Pharma Consulting (IFPC)

Eoin Moloney
Health Economics & Outcomes Research

Santoke Naal
General Manager IGES UK Pharma Consulting (IUPC)

Rohan Naal
Market Access UK

Corinne Perret
HTA & Value Demonstration

Stefan Reindl
HTA & Value Demonstration

Elena Reith
Value & Access Strategy

Dr. Stephan Ruckdäschel
Managing Director HealthEcon | CH

Brigitte Roch
Market Access France

Teresa Romaguera
HTA & Value Demonstration

Guido Schiffhorst
Director of Statistics & Biometrics

Evelyn Elisabeth Schlegl-Zanetti
HTA & Value Demonstration

Dr. David Steinl
HTA & Value Demonstration

Stephanie Sussmann
Value & Access Strategy

Dr. Ilda Theka
General Manager IGES Italy Pharma Consulting (IIPC)

Thanh Thao Tran
Value & Access Strategy

Dr. Silvia Uecker
Clinical Research

Eveline van Eerd
HTA & Value Demonstration

Lara Luisa Wolff
Value & Access Strategy

Martha Wolfram
Value & Access Strategy

Dr. Elke Ziegler
HTA & Value Demonstration

Johannes Ziemen
HTA & Value Demonstration
Further Team Members
- Nikola Göttler | HTA & Value Demonstration
- Jocelyn Hu | Market Access UK
- Patrick Lambert | Clinical Research
- Dr. Jana Maresch | HTA & Value Demonstration
- Dr. Barbara Obertreis | HTA & Value Demonstration
- Christina Reisinger | HTA & Value Demonstration
- Maciej Rowinski | Statistics & Biometrics
- Zihao Wu | Market Access UK